InChI=1S/C15H22FN3O6/c1-3-4-5-6-24-15(23)18-12-9(16)7-19(14(22)17-12)13-11(21)10(20)8(2)25-13/h7-8,10-11,13,20-21H,3-6H2,1-2H3,(H,17,18,22,23)/t8-,10-,11-,13-/m1/s1 |
GAGWJHPBXLXJQN-UORFTKCHSA-N |
CCCCCOC(=O)Nc1nc(=O)n(cc1F)[C@@H]1O[C@H](C)[C@@H](O)[C@H]1O |
|
antimetabolite
A substance which is structurally similar to a metabolite but which competes with it or replaces it, and so prevents or reduces its normal utilization.
|
|
prodrug
A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug.
antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
|
|
View more via ChEBI Ontology
5'-deoxy-5-fluoro-N-[(pentyloxy)carbonyl]cytidine
|
capecitabina
|
ChEBI
|
capécitabine
|
ChEBI
|
capecitabine
|
KEGG DRUG
|
capecitabinum
|
ChEBI
|
(1-(5-Deoxy-beta-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinyl)-carbamic acid pentyl ester
|
KEGG COMPOUND
|
Capecitabin
|
ChEBI
|
pentyl 1-(5-deoxy-β-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinecarbamate
|
ChemIDplus
|
Pentyl [1-(5-deoxy-β-D-ribofuranosyl)-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl]carbamate
|
IUPAC
|
154361-50-9
|
CAS Registry Number
|
ChemIDplus
|
8583270
|
Reaxys Registry Number
|
Reaxys
|
|
|